8-KThe WireRed Alert
Executive Change
Filed Apr 10, 2026 · 2mo ago · Accession 0001193125-26-151220
Plain English
Bruker Corporation announced the departure of Falko Busse, Ph.D., executive officer and President of Bruker BioSpin, effective October 31, 2026, with a separation agreement providing approximately CHF $1,020,351 in benefits.
Filing details
- Company
- BRUKER CORP
- Ticker
- BRKR
- CIK
- 1109354
- Form type
- 8-K
- Filing date
- Apr 10, 2026
- Report date
- Apr 10, 2026
- Document
- brkr-20260410.htm
- Size
- 187 KB